The CTLL-2 bioassay is used frequently to determine interleukin-2 (IL-
2) concentrations in experimental samples, including samples that cont
ain reagents which affect the CD28-B7 interaction. We therefore evalua
ted whether the CD28-B7 pathway plays a role in the growth of CTLL-2 c
ells. Flow cytometry demonstrated that CTLL-2 cells express both CD28
and B7-1. CTLA4-immunoglobulin (CTLA4-Ig) inhibited the growth of CTLL
-2 cells over a range of IL-2 concentrations, suggesting that the CD28
-B7 interaction plays an important role in the growth of CTLL-2 cells.
Anti-B7-1 antibody also inhibited CTLL-2 proliferation at all concent
rations of IL-2. These results indicate that the CTLL-2 bioassay may n
ot be a reliable means of determining IL-2 levels in experimental samp
les containing reagents that affect the CD28-B7 interaction. They also
suggest that co-expression of CD28 and B7 may contribute to the growt
h of malignant T cells.